Reduction of antileukemic and immunosuppressive activities of 5-azacytidine in mice by concurrent treatment with uridine.
D000818:Animals; D000921:Antibody-Producing Cells / Q000187:drug effects; D000970:Antineoplastic Agents / Q000037:antagonists & inhibitors*; D001853:Bone Marrow / Q000187:drug effects*; D001854:Bone Marrow Cells; D004336:Drug Antagonism; D006386:Hemagglutination Tests; D006462:Hemolytic Plaque Technique; D007166:Immunosuppressive Agents / Q000037:antagonists & inhibitors*; D007939:Leukemia L1210 / Q000188:drug therapy*; D008297:Male; D051379:Mice; D009705:Nucleosides / Q000037:antagonists & inhibitors*; D013154:Spleen / Q000166:cytology / Q000276:immunology*; D014529:Uridine / Q000494:pharmacology*
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D009705:Nucleosides; D014529:Uridine